Technology-driven excipients and specialty-ingredients maker Sudeep Pharma Ltd has secured ₹268 crore from anchor investors including Mukul Agrawal and Prashant Jain ahead of its ₹895 crore IPO opening on 21 November 2025. The strong anchor book bolsters market confidence in the issue, which includes a fresh issue of ₹95 crore and an Offer for Sale (OFS) component worth ~₹800 crore at the upper price band. The company’s focus on pharma, food and nutrition market segments underpins investor interest.